GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Central Pharmaceutical JSC No2 (HSTC:DP2) » Definitions » Net Income Including Noncontrolling Interests

Central Pharmaceutical JSC No2 (HSTC:DP2) Net Income Including Noncontrolling Interests : ₫0.00 Mil (TTM As of . 20)


View and export this data going back to 2017. Start your Free Trial

What is Central Pharmaceutical JSC No2 Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Central Pharmaceutical JSC No2's Net Income Including Noncontrolling Interests for the six months ended in . 20 was ₫0.00 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in . 20 was ₫0.00 Mil.

Central Pharmaceutical JSC No2 Net Income Including Noncontrolling Interests Historical Data

The historical data trend for Central Pharmaceutical JSC No2's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Central Pharmaceutical JSC No2 Net Income Including Noncontrolling Interests Chart

Central Pharmaceutical JSC No2 Annual Data
Trend
Net Income Including Noncontrolling Interests

Central Pharmaceutical JSC No2 Semi-Annual Data
Net Income Including Noncontrolling Interests

Central Pharmaceutical JSC No2 Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in . 20 was ₫0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Central Pharmaceutical JSC No2 Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of Central Pharmaceutical JSC No2's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

Central Pharmaceutical JSC No2 (HSTC:DP2) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Central Pharmaceutical JSC No2 (HSTC:DP2) » Definitions » Net Income Including Noncontrolling Interests
Comparable Companies
Traded in Other Exchanges
N/A
Address
No. 9 Tran Thanh Tong, Bach Dang Ward, Hai Ba Trung District, Hanoi, VNM
Website
https://www.dopharma.vn
Central Pharmaceutical JSC No2 is engaged in the Trading of medicinal materials, pharmaceutical materials, chemicals, essential oils, modern medicines, traditional medicine drugs, cosmetics, and nutritious foods. Some of its products include Gentamycin injection solution 80; Genatreson Skin Cream; Ferimax Hard Capsules and others.

Central Pharmaceutical JSC No2 (HSTC:DP2) Headlines

No Headlines